Abstract:Background: Alternative splicing of TTN I-band exons produce protein isoforms with variable size and elasticity, but the mechanisms regulating TTN exon skipping and isoform composition in the human heart are not well studied. Non-coding antisense transcripts have been shown to regulate alternative splicing of the sense gene. The TTN gene locus harbours antisense transcripts with unknown function in the human heart. The aim of this study was to determine if TTN antisense transcripts play a role in alternative splicing of TTN. Methods: RNA-sequencing and RNA in situ hybridization (ISH) of cardiac tissue from unused donor hearts (n=7) and human induced pluripotent stem cell-derived cardiomyocytes (iPS-CMs) were used to determine the expression and localization of TTN antisense transcripts. The effect of siRNA-mediated knock down of TTN antisense transcripts on TTN exon usage in iPS-CMs was determined using RNA-sequencing. Live cell imaging was used to analyze the effect of antisense transcript knock down on sarcomere properties. RNA ISH, immunofluorescence and high content microscopy was performed in iPS-CMs to study the interaction between antisense transcripts, TTN mRNA and splice factor protein RBM20. Results: In mapping TTN antisense transcription, we found that TTN-AS1-276 was the predominant transcript in the human heart and that it was mainly localized in cardiomyocyte nuclei. Knock down of TTN-AS1-276 in human iPS-CMs resulted in decreased interaction between the splicing factor RBM20 and TTN pre-mRNA, decreased TTN I-band exon skipping, and markedly lower expression of the stiff N2B isoform Furthermore, knockdown resulted in longer sarcomeres with preserved alignment, improved fractional shortening and relaxation times. Conclusions: We demonstrate a role for the cardiac TTN antisense transcript TTN-AS1-276 in facilitating alternative splicing of TTN and regulating sarcomere properties. This transcript could constitute a target for improving cardiac passive stiffness and diastolic function in conditions such as heart failure with preserved ejection fraction.

Genetic excision of the regulatory cardiac troponin I extension in high heart rate mammal clades

Genetic excision of the regulatory cardiac troponin I extension in high–heart rate mammal clades

Early Divergence of the C-Terminal Variable Region of Troponin T Via a Pair of Mutually Exclusive Alternatively Spliced Exons Followed by a Selective Fixation in Vertebrate Heart

Myopathic Splice-Out of the Exon 7 Segment of Cardiac Troponin T Predominantly Impairs Systolic Function of the Heart

Abstract 137: The Role of TNNI3K in Adult Mammalian Heart Regeneration

Expression Levels of the Tnni3k Gene in the Heart Are Highly Associated with Cardiac and Glucose Metabolism-Related Phenotypes and Functional Pathways

Tnni3k, A Cardiac-Specific Kinase, Promotes Physiological Cardiac Hypertrophy In Transgenic Mice

Evolution of the N-Terminal Regulation of Cardiac Troponin I for Heart Function of Tetrapods: Lungfish Presents an Example of the Emergence of Novel Submolecular Structure to Lead the Capacity of Adaptation

Abnormal Splicing in the N-terminal Variable Region of Cardiac Troponin T Impairs Systolic Function of the Heart with Preserved Frank-Starling Compensation.

Phosphorylation, but Not Alternative Splicing or Proteolytic Degradation, is Conserved in Human and Mouse Cardiac Troponin T.

Identification and characterization of a cardiac-specific transcriptional regulatory element in the slow/cardiac troponin C gene

Fetal Cardiac Troponin Isoforms Rescue the Increased Ca2+ Sensitivity Produced by a Novel Double Deletion in Cardiac Troponin T Linked to Restrictive Cardiomyopathy

Structure of the NH2-terminal Variable Region of Cardiac Troponin T Determines Its Sensitivity to Restrictive Cleavage in Pathophysiological Adaptation

Cardiomyocyte antisense transcription regulates exon usage in the elastic spring region of Titin to modulate sarcomere function

Increasing mammalian cardiomyocyte contractility with residues identified in trout troponin C

TNNI3K is a Novel Mediator of Myofilament Function and Phosphorylates Cardiac Troponin I

Intranuclear Cardiac Troponin I Plays a Functional Role in Regulating Atp2a2 Expression in Cardiomyocytes

Modeling of Transgenic Mice Cardiac- Specifically Overexpressing Human KCNE4 Gene

Tissue-specific Alternative Splicing of Ascidian Troponin I Isoforms

Whole Exome Sequencing Identifies a Novel Mutation (c.333 + 2T > C) of TNNI3K in a Chinese Family with Dilated Cardiomyopathy and Cardiac Conduction Disease.

The Heart-Specific NH2-terminal Extension Regulates the Molecular Conformation and Function of Cardiac Troponin I